TNThierry Nyatanyi

Thierry Nyatanyi

*This is an algorithmically generated author record based on publicly available information.

Thierry Nyatanyi has a total of 175 co-authors. Here are the top co-authors by number of shared publications:

  • Adeline Kabeja

    Epidemic Surveillance and Response Division, Rwanda Biomedical Center, Ministry of Health, Kigali, Rwanda

    4 shared publications
  • Agnes Binagwaho

    Harvard Medical School, Boston, Massachusetts, USA

    4 shared publications
  • Corine Karema

    Rwanda Biomedical Center, Kigali, Rwanda

    4 shared publications
  • Jean Baptiste Koama

    Influenza Program, Centers for Disease Control and Prevention, Kigali, Rwanda

    4 shared publications
  • Alice Kabanda

    National Reference Laboratory, Rwanda Biomedical Center, Ministry of Health, Kigali, Rwanda

    3 shared publications
  • Jared Omolo

    Influenza Program, Centers for Disease Control and Prevention, Kigali, Rwanda

    3 shared publications

Latest Publications

  • Open Access

    Global One Health Case Competition: Building Capacity for Addressing Infectious Threats

    by Carolyn M. Porta, Robert Kibuuka, Innocent B. Rwego, Thierry Nyatanyi, Mapendo Mindje, Benjamin Ndayambaje, Besufekad Alemu

    Extracurricular inter-professional activities advance pre-service student skills and confidence before joining the workforce. This article describes an extracurricular model, whereby students engaged in experiential learning, and had the opportunity to challenge themselves in interprofessional groups guided by faculty and inspired by professionals in their respective fields. The Global One Health Case Competition involved students from the University of Rwanda in collaboration with the University of Minnesota, and required students in teams to address an Ebola outbreak containment and response scenario. Forty students, seven faculty coaches, and five judges participated in this event. Students gained collaborative teamwork skills as they developed comprehensive strategies for managing a response to a zoonotic disease outbreak, considering political, financial, logistical, and other factors. Faculty strengthened skills in writing complex case studies for a competition model, and in mentoring of multidisciplinary student groups. Case competition is an effective educational mechanism for building the outbreak response capacity of our future workforce before they are in their real-world professional roles responding to actual zoonotic and other infectious disease threats.


  • Open Access

    The national burden of influenza‐associated severe acute respiratory illness hospitalization in Rwanda, 2012‐2014

    by José Nyamusore, Joseph Rukelibuga, Mwumvaneza Mutagoma, Andrew Muhire, Alice Kabanda, Thelma Williams, Angela Mutoni, Julius Kamwesiga, Thierry Nyatanyi, Jared Omolo, et al.

    Background: Estimates of influenza‐associated hospitalization are severely limited in low‐ and middle‐income countries, especially in Africa.Objectives: To estimate the national number of influenza‐associated severe acute respiratory illness (SARI) hospitalization in Rwanda.Methods: We multiplied the influenza virus detection rate from influenza surveillance conducted at 6 sentinel hospitals by the national number of respiratory hospitalization obtained from passive surveillance after adjusting for underreporting and reclassification of any respiratory hospitalizations as SARI during 2012‐2014. The population at risk was obtained from projections of the 2012 census. Bootstrapping was used for the calculation of confidence intervals (CI) to account for the uncertainty associated with all levels of adjustment. Rates were expressed per 100 000 population. A sensitivity analysis using a different estimation approach was also conducted.Results: SARI cases accounted for 70.6% (9759/13 813) of respiratory admissions at selected hospitals: 77.2% (6783/8786) and 59.2% (2976/5028) among individuals aged <5 and ≥5 years, respectively. Overall, among SARI cases tested, the influenza virus detection rate was 6.3% (190/3022): 5.7% (127/2220) and 7.8% (63/802) among individuals aged <5 and ≥5 years, respectively. The estimated mean annual national number of influenza‐associated SARI hospitalizations was 3663 (95% CI: 2930‐4395—rate: 34.7; 95% CI: 25.4‐47.7): 2637 (95% CI: 2110‐3164—rate: 168.7; 95% CI: 135.0‐202.4) among children aged <5 years and 1026 (95% CI: 821‐1231—rate: 11.3; 95% CI: 9.0‐13.6) among individuals aged ≥5 years. The estimates obtained from both approaches were not statistically different (overlapping CIs).Conclusions: The burden of influenza‐associated SARI hospitalizations was substantial and was highest among children aged <5 years.


  • Open Access

    Implementing One Health as an integrated approach to health in Rwanda

    by Thierry Nyatanyi, Michael Wilkes, Haley McDermott, Serge Nzietchueng, Isidore Gafarasi, Antoine Mudakikwa, Jean Felix Kinani, Joseph Rukelibuga, Jared Omolo, Denise Mupfasoni, et al.

    It is increasingly clear that resolution of complex global health problems requires interdisciplinary, intersectoral expertise and cooperation from governmental, non-governmental and educational agencies. ‘One Health’ refers to the collaboration of multiple disciplines and sectors working locally, nationally and globally to attain optimal health for people, animals and the environment. One Health offers the opportunity to acknowledge shared interests, set common goals, and drive toward team work to benefit the overall health of a nation. As in most countries, the health of Rwanda's people and economy are highly dependent on the health of the environment. Recently, Rwanda has developed a One Health strategic plan to meet its human, animal and environmental health challenges. This approach drives innovations that are important to solve both acute and chronic health problems and offers synergy across systems, resulting in improved communication, evidence-based solutions, development of a new generation of systems-thinkers, improved surveillance, decreased lag time in response, and improved health and economic savings. Several factors have enabled the One Health movement in Rwanda including an elaborate network of community health workers, existing rapid response teams, international academic partnerships willing to look more broadly than at a single disease or population, and relative equity between female and male health professionals. Barriers to implementing this strategy include competition over budget, poor communication, and the need for improved technology. Given the interconnectedness of our global community, it may be time for countries and their neighbours to follow Rwanda's lead and consider incorporating One Health principles into their national strategic health plans.


  • A Mixed Outbreak of Epidemic Typhus Fever and Trench Fever in a Youth Rehabilitation Center: Risk Factors for Illness from a Case-Control Study, Rwanda, 2012

    by Irenee Umulisa, Jared Omolo, Katherine A. Muldoon, Jeannine Condo, Francois Habiyaremye, Jean Marie Uwimana, Marie Aimee Muhimpundu, Tura Galgalo, Samuel Rwunganira, Anicet G. Dahourou, et al.

    In August 2012, laboratory tests confirmed a mixed outbreak of epidemic typhus fever and trench fever in a male youth rehabilitation center in western Rwanda. Seventy-six suspected cases and 118 controls were enrolled into an unmatched case-control study to identify risk factors for symptomatic illness during the outbreak. A suspected case was fever or history of fever, from April 2012, in a resident of the rehabilitation center. In total, 199 suspected cases from a population of 1,910 male youth (attack rate = 10.4%) with seven deaths (case fatality rate = 3.5%) were reported. After multivariate analysis, history of seeing lice in clothing (adjusted odds ratio [aOR] = 2.6, 95% confidence interval [CI] = 1.1–5.8), delayed (≥ 2 days) washing of clothing (aOR = 4.0, 95% CI = 1.6–9.6), and delayed (≥ 1 month) washing of beddings (aOR = 4.6, 95% CI = 2.0–11) were associated with illness, whereas having stayed in the rehabilitation camp for ≥ 6 months was protective (aOR = 0.20, 95% CI = 0.10–0.40). Stronger surveillance and improvements in hygiene could prevent future outbreaks.


  • Open Access

    Severe Acute Respiratory Illness Deaths in Sub-Saharan Africa and the Role of Influenza: A Case Series From 8 Countries

    by Meredith L. McMorrow, Emile Okitolonda Wemakoy, Joelle Kabamba Tshilobo, Gideon O. Emukule, Joshua A. Mott, Henry Njuguna, Lilian Waiboci, Jean-Michel Heraud, Soatianana Rajatonirina, Norosoa H. Razanajatovo, et al.

    Background. Data on causes of death due to respiratory illness in Africa are limited. Methods. From January to April 2013, 28 African countries were invited to participate in a review of severe acute respiratory illness (SARI)–associated deaths identified from influenza surveillance during 2009–2012. Results. Twenty-three countries (82%) responded, 11 (48%) collect mortality data, and 8 provided data. Data were collected from 37 714 SARI cases, and 3091 (8.2%; range by country, 5.1%–25.9%) tested positive for influenza virus. There were 1073 deaths (2.8%; range by country, 0.1%–5.3%) reported, among which influenza virus was detected in 57 (5.3%). Case-fatality proportion (CFP) was higher among countries with systematic death reporting than among those with sporadic reporting. The influenza-associated CFP was 1.8% (57 of 3091), compared with 2.9% (1016 of 34 623) for influenza virus–negative cases (P < .001). Among 834 deaths (77.7%) tested for other respiratory pathogens, rhinovirus (107 [12.8%]), adenovirus (64 [6.0%]), respiratory syncytial virus (60 [5.6%]), and Streptococcus pneumoniae (57 [5.3%]) were most commonly identified. Among 1073 deaths, 402 (37.5%) involved people aged 0–4 years, 462 (43.1%) involved people aged 5–49 years, and 209 (19.5%) involved people aged ≥50 years. Conclusions. Few African countries systematically collect data on outcomes of people hospitalized with respiratory illness. Stronger surveillance for deaths due to respiratory illness may identify risk groups for targeted vaccine use and other prevention strategies.


  • Rwanda 20 years on: investing in life

    by Agnes Binagwaho, Paul E Farmer, Sabin Nsanzimana, Corine Karema, Michel Gasana, Jean de Dieu Ngirabega, Fidele Ngabo, Claire M Wagner, Cameron T Nutt, Thierry Nyatanyi, et al.


  • Open Access

    A National Electronic System for Disease Surveillance in Rwanda (eIDSR): Lessons Learned from a Successful Implementation

    by Nyatanyi Thierry, Kabeja Adeline, Asiimwe Anita, Binagwaho Agnes, Koama Jean Baptiste, Johnson Pamela, Kayumba Kizito

    A National Electronic System for Disease Surveillance in Rwanda (eIDSR): Lessons Learned from a Successful Implementation


  • Open Access

    Influenza Sentinel Surveillance in Rwanda, 2008–2010

    by Thierry Nyatanyi, Richard Nkunda, Joseph Rukelibuga, Rakhee Palekar, Marie Aimée Muhimpundu, Adeline Kabeja, Alice Kabanda, David Lowrance, Stefano Tempia, Jean Baptiste Koama, et al.

    Background. In 2008, Rwanda established an influenza sentinel surveillance (ISS) system to describe the epidemiology of influenza and monitor for the emergence of novel influenza A viruses. We report surveillance results from August 2008 to July 2010. Methods. We conducted ISS by monitoring patients with influenza-like illness (ILI) and severe acute respiratory infection (SARI) at 6 hospitals. For each case, demographic and clinical data, 1 nasopharyngeal specimen, and 1 oropharyngeal specimen were collected. Specimens were tested by real-time reverse-transcription polymerase chain reaction for influenza A and B viruses at the National Reference Laboratory in Rwanda. Results. A total of 1916 cases (945 ILI and 971 SARI) were identified. Of these, 29.2% (n = 276) of ILI and 10.4% (n = 101) of SARI cases tested positive for influenza. Of the total influenza-positive cases (n = 377), 71.8% (n = 271) were A(H1N1) pdm09, 5.6% (n = 21) influenza A(H1), 7.7% (n = 29) influenza A(H3), 1.6% (n = 6) influenza A (unsubtyped), and 13.3% (n = 50) influenza B. The percentage of positivity for influenza viruses was highest in October–November and February–March, during peaks in rainfall. Conclusions. The implementation of ISS enabled characterization of the epidemiology and seasonality of influenza in Rwanda for the first time. Future efforts should determine the population-based influenza burden to inform interventions such as targeted vaccination.


  • Support for a cholera vaccine stockpile

    by Agnes Binagwaho, Thierry Nyatanyi, Cameron T. Nutt, Claire M. Wagner


  • Open Access

    2009 Pandemic Influenza A (H1N1) Virus Outbreak and Response – Rwanda, October, 2009–May, 2010

    by Justin Wane, Thierry Nyatanyi, Richard Nkunda, Joseph Rukelibuga, Zara Ahmed, Caitlin Biedron, Adeline Kabeja, Marie Aimée Muhimpundu, Alice Kabanda, Simon Antara, et al.

    In October 2009, the first case of pandemic influenza A(H1N1)pdm09 (pH1N1) was confirmed in Kigali, Rwanda and countrywide dissemination occurred within several weeks. We describe clinical and epidemiological characteristics of this epidemic. From October 2009 through May 2010, we undertook epidemiologic investigations and response to pH1N1. Respiratory specimens were collected from all patients meeting the WHO case definition for pH1N1, which were tested using CDC’s real time RT-PCR protocol at the Rwandan National Reference Laboratory (NRL). Following documented viral transmission in the community, testing focused on clinically severe and high-risk group suspect cases. From October 9, 2009 through May 31, 2010, NRL tested 2,045 specimens. In total, 26% (n = 532) of specimens tested influenza positive; of these 96% (n = 510) were influenza A and 4% (n = 22) were influenza B. Of cases testing influenza A positive, 96.8% (n = 494), 3% (n = 15), and 0.2% (n = 1) were A(H1N1)pdm09, Seasonal A(H3) and Seasonal A(non-subtyped), respectively. Among laboratory-confirmed cases, 263 (53.2%) were children <15 years and 275 (52%) were female. In total, 58 (12%) cases were hospitalized with mean duration of hospitalization of 5 days (Range: 2–15 days). All cases recovered and there were no deaths. Overall, 339 (68%) confirmed cases received oseltamivir in any setting. Among all positive cases, 26.9% (143/532) were among groups known to be at high risk of influenza-associated complications, including age <5 years 23% (122/532), asthma 0.8% (4/532), cardiac disease 1.5% (8/532), pregnancy 0.6% (3/532), diabetes mellitus 0.4% (2/532), and chronic malnutrition 0.8% (4/532). Rwanda experienced a PH1N1 outbreak which was epidemiologically similar to PH1N1 outbreaks in the region. Unlike seasonal influenza, children <15 years were the most affected by pH1N1. Lessons learned from the outbreak response included the need to strengthen integrated disease surveillance, develop laboratory contingency plans, and evaluate the influenza sentinel surveillance system.